Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2025-12-26 @ 3:58 AM
Study NCT ID:
NCT00217594
Status:
COMPLETED
Last Update Posted:
2018-10-30
First Post:
2005-09-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome
Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-07-21
Start Date Type:
None
Primary Completion Date:
2017-02-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-02-06
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-20
First Submit QC Date:
None
Study First Post Date:
2005-09-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-08-23
Results First Submit QC Date:
None
Results First Post Date:
2018-09-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-04
Last Update Post Date:
2018-10-30
Last Update Post Date Type:
ACTUAL